Prevalence of germline TP53 mutations in HER2+ breast cancer patients. - Wikidata - wikimedia - TriplyDB

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

http://www.wikidata.org/entity/Q34789542

about

The Promise of Preventive Cancer Vaccines Integrated analysis of germline and somatic variants in ovarian cancer.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Next generation sequencing is informing phenotype: a TP53 example.

P2860

Q26783742-B55A8DE4-FD99-4258-8651-40E98B85A803 Q33630954-892B442E-C373-490E-9538-5BAADB103E41 Q36717196-D8D7EA6B-91BB-4CAB-8FC0-014FD9A265F7 Q38184454-4AFD81E7-C648-4B86-AF99-6FACA99E978D Q38202612-117367DB-EB3F-4E33-AAC8-E073909FC2B7 Q38364614-8F327E68-E88E-4A6A-AE54-29FF7A434E77 Q38783154-C296C297-0B4E-423C-BBB6-C95133CFC825

P2860

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

http://www.wikidata.org/entity/Q34789542

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@ast

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@en

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@nl

type

label

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@ast

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@en

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@nl

prefLabel

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@ast

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@en

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@nl

P1433

Q34789542-A3866C01-F8B3-4367-B463-12CB405E5457

P1476

Q34789542-D5CD7C92-5E43-4041-BCA1-D77B92246F59

P2093

Q34789542-0977E911-CB2D-49A2-B0F2-CF8A10B7B204

Q34789542-3BEF05BF-ABB5-4956-9673-7AAE07D0320C

Q34789542-50AC8C54-82CA-4FF0-9A23-E6ADDE1265D5

Q34789542-5B5FEADB-DBAF-4AFC-87F0-E5126BBC49F7

Q34789542-5D96B279-79FE-4B9D-B509-A3D758EA88F2

Q34789542-8F9AC4A3-B269-41FD-B494-D405A0192E4C

Q34789542-9ED3AB91-1444-4112-B3B9-70EC8C43983F

Q34789542-AFB379B2-BE8B-430C-A44A-8571D7A487DA

Q34789542-E3A061F3-3398-4D85-ABC0-41DF3AAAEE40

Q34789542-E8D5AFD6-A0A0-4911-A971-8F7DFBC704C2

P2860

Q34789542-13D852E4-51FA-45D5-9C27-C74466ECF96C

Q34789542-246AF95E-E5B2-46F3-974C-E1E422B158F2

Q34789542-3C6E3159-78C6-43C5-B3DA-652C61D36898

Q34789542-41852436-C393-438A-B57D-41B136D95816

Q34789542-53BA109D-046C-406B-AC93-D2FA405C7F64

Q34789542-5943B98C-AB35-48B4-8153-A055F5715DD4

Q34789542-5ED68326-F123-4863-8E0A-AD568103E73E

Q34789542-641B98AB-E449-48B0-A72B-0BDB8E6E6F87

Q34789542-6586D2F5-E207-45FA-A784-C703FFD0283E

Q34789542-66A4E5EE-E094-476C-B08C-4AE1185E8493

P2888

Q34789542-82151B62-EE99-4B65-9DE4-ACC9CD09B418

P304

Q34789542-90CECFA5-96E0-4ACC-B576-C6BCC93FA5FD

P31

Q34789542-2D1BCD0B-3749-4FDE-8590-3E5528E6CEA4

P356

Q34789542-656F3994-F35D-4B0F-A568-8F8B1CBADCFF

P407

Q34789542-AB6C2412-064E-4312-9580-9B76707302DD

P433

Q34789542-1B665F22-73DF-4E40-A00A-71C0CF45AC9F

P478

Q34789542-5FFCC597-F55B-4504-B30F-5F6565D2DFA1

P50

Q34789542-86669210-F18F-4E63-AB14-5251E013928A

P577

Q34789542-D0B5B8E2-5F32-4867-BCC3-A68E3CECBDA7

P6179

Q34789542-37BFAE56-AF2B-4BEB-AF76-1900FE593560

P698

Q34789542-A2CC4034-2D08-4504-9945-2B86BC26BDAF

P932

Q34789542-51C4CAE6-D6E4-492F-B9A8-135052676498

P356

S10549-012-2375-Z

P1433

Breast Cancer Research and Treatment

P1476

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

@en

P2093

Alexander Miron

http://www.w3.org/2001/XMLSchema#string

Andrea L Richardson

http://www.w3.org/2001/XMLSchema#string

Deborah A Dillon

http://www.w3.org/2001/XMLSchema#string

Ian E Krop

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Michelle G Rath

http://www.w3.org/2001/XMLSchema#string

Penelope Miron

http://www.w3.org/2001/XMLSchema#string

Rebecca Gelman

http://www.w3.org/2001/XMLSchema#string

Serena Masciari

http://www.w3.org/2001/XMLSchema#string

Sigitas J Verselis

http://www.w3.org/2001/XMLSchema#string

P2860

IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

A cancer family syndrome in twenty-four kindreds.

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Tumors associated with p53 germline mutations: a synopsis of 91 families.

Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing.

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.

Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

P2888

s10549-012-2375-z

P304

193-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-012-2375-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Kathleen M. Foley

P577

2013-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044697020

http://www.w3.org/2001/XMLSchema#string

P698

23580068

http://www.w3.org/2001/XMLSchema#string

P932

4280061

http://www.w3.org/2001/XMLSchema#string